Bligh James 4
4 · CONDUIT PHARMACEUTICALS INC. · Filed Nov 20, 2024
Insider Transaction Report
Form 4
Bligh James
DirectorCFO
Transactions
- Award
Stock Option (Right to Buy)
2024-11-18$0.09/sh+1,890,000$173,691→ 1,890,000 totalExercise: $0.09Exp: 2034-11-18→ Common Stock (1,890,000 underlying)
Footnotes (2)
- [F1]Represents Options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan.
- [F2]The Options vest as follows: (i) 50% on the grant date and (ii) 50% in equal annual installments on the first three anniversaries of the grant date.